Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Schiappacassi

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
International Journal of Molecular Sciences|July 14, 2023
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical ImplicationsElisa Bertoli, Elisa De Carlo, Debora Basile, et al.
Oncotarget|January 23, 2014
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancerFrancesca Lovat, Hideshi Ishii, Monica Schiappacassi, et al.
Journal of Molecular Cell Biology|October 10, 2015
SUMOylation regulates p27Kip1 stability and localization in response to TGFβSara Lovisa, Simona Citro, Maura Sonego, et al.
The Journal of Pathology|July 8, 2003
Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situGaetano Magro, Monica Schiappacassi, Daniela Perissinotto, et al.
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
In Vivo (Athens, Greece)|August 19, 2021
Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case ReportElisa DE Carlo, Monica Schiappacassi, Giacomo Pelizzari, et al.
Oncotargets and Therapy|December 22, 2018
Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case reportElisa De Carlo, Monica Schiappacassi, Martina Urbani, et al.
The American Journal of Pathology|June 24, 2003
Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomasGaetano Magro, Daniela Perissinotto, Monica Schiappacassi, et al.
Molecular Biology of the Cell|February 29, 2008
Stathmin activity influences sarcoma cell shape, motility, and metastatic potentialBarbara Belletti, Milena S Nicoloso, Monica Schiappacassi, et al.
Scientific Reports|April 6, 2017
Loss of p27<sup>kip1</sup> increases genomic instability and induces radio-resistance in luminal breast cancer cellsStefania Berton, Martina Cusan, Ilenia Segatto, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|July 14, 2023
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical ImplicationsElisa Bertoli, Elisa De Carlo, Debora Basile, et al.
Oncotarget|January 23, 2014
LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancerFrancesca Lovat, Hideshi Ishii, Monica Schiappacassi, et al.
Journal of Molecular Cell Biology|October 10, 2015
SUMOylation regulates p27Kip1 stability and localization in response to TGFβSara Lovisa, Simona Citro, Maura Sonego, et al.
The Journal of Pathology|July 8, 2003
Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situGaetano Magro, Monica Schiappacassi, Daniela Perissinotto, et al.
Frontiers in Oncology|April 2, 2026
BRAF class II-III mutations in NSCLC: a single center experienceSara Torresan, Martina Bortolot, Elisa Bertoli, et al.
In Vivo (Athens, Greece)|August 19, 2021
Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case ReportElisa DE Carlo, Monica Schiappacassi, Giacomo Pelizzari, et al.
Oncotargets and Therapy|December 22, 2018
Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case reportElisa De Carlo, Monica Schiappacassi, Martina Urbani, et al.
The American Journal of Pathology|June 24, 2003
Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomasGaetano Magro, Daniela Perissinotto, Monica Schiappacassi, et al.
Molecular Biology of the Cell|February 29, 2008
Stathmin activity influences sarcoma cell shape, motility, and metastatic potentialBarbara Belletti, Milena S Nicoloso, Monica Schiappacassi, et al.
Scientific Reports|April 6, 2017
Loss of p27<sup>kip1</sup> increases genomic instability and induces radio-resistance in luminal breast cancer cellsStefania Berton, Martina Cusan, Ilenia Segatto, et al.
Pageof 4